Skip to content

Celcuity CELC Net Income

Net Income at other companies

Eli Lilly logo
Eli LillyLLY
$7.4B+168%
Gilead Sciences logo
Gilead SciencesGILD
$2.02B+53.7%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
-$166.56M+1.8%
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
-$73.29M+4.9%
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
-$97.35M-35.2%
Tango Therapeutics logo
Tango TherapeuticsTNGX
-$45.51M-14.1%

Other financials

Income statement

See full
Operating income-$50.5M-39.8%
EPS (diluted)-$0.97-12.8%

Balance sheet

See full
Cash & equivalents$145.2M+781%
Total debt$137.9M+30.7%
Total equity$53.5M-38.2%
Total assets$410.2M+88.0%

Cash flow

See full
Operating cash flow-$55.1M-53.6%
CapEx$249.0K+315%
Free cash flow-$55.3M-54.0%

Valuation

See full
Market cap$4.28B+1,370%
Enterprise value$4.27B+1,086%

Returns & leverage

See full
Return on equity-275.2%-990pp
Debt / equity2.6×+1.4×
Current ratio12.3×+5.7×

Where this comes from

Reported directly by Celcuity in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The official record: Celcuity’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Celcuity's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Celcuity's net income?
Celcuity (CELC) reported net income of -$52.84M in Q1 2026.
How has Celcuity's net income changed year-over-year?
Celcuity's net income decreased by 42.8% year-over-year, from -$37M to -$52.84M.
What is the long-term trend for Celcuity's net income?
Over 4 years (2021 to 2025), Celcuity's net income has grown at a 56.4% compound annual growth rate (CAGR), from -$29.61M to -$177.04M.
What does net income mean?
The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.